
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Role of Neuropilin 1 in COVID-19 Patients with Acute Ischemic Stroke
Asma W. Al-Thomali, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Biomedicines (2022) Vol. 10, Iss. 8, pp. 2032-2032
Open Access | Times Cited: 40
Asma W. Al-Thomali, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Biomedicines (2022) Vol. 10, Iss. 8, pp. 2032-2032
Open Access | Times Cited: 40
Showing 1-25 of 40 citing articles:
Pathophysiology of Post-COVID syndromes: a new perspective
Gaber El‐Saber Batiha, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Virology Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 93
Gaber El‐Saber Batiha, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Virology Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 93
Role of ketogenic diet in neurodegenerative diseases focusing on Alzheimer diseases: The guardian angle
Hayder M. Al‐kuraishy, Majid S. Jabir, Ali K. Albuhadily, et al.
Ageing Research Reviews (2024) Vol. 95, pp. 102233-102233
Closed Access | Times Cited: 17
Hayder M. Al‐kuraishy, Majid S. Jabir, Ali K. Albuhadily, et al.
Ageing Research Reviews (2024) Vol. 95, pp. 102233-102233
Closed Access | Times Cited: 17
Statins Use in Alzheimer Disease: Bane or Boon from Frantic Search and Narrative Review
Nawal Alsubaie, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Brain Sciences (2022) Vol. 12, Iss. 10, pp. 1290-1290
Open Access | Times Cited: 53
Nawal Alsubaie, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Brain Sciences (2022) Vol. 12, Iss. 10, pp. 1290-1290
Open Access | Times Cited: 53
A Potential Link Between Visceral Obesity and Risk of Alzheimer’s Disease
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Abdulrahman A. Alsayegh, et al.
Neurochemical Research (2022) Vol. 48, Iss. 3, pp. 745-766
Closed Access | Times Cited: 53
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Abdulrahman A. Alsayegh, et al.
Neurochemical Research (2022) Vol. 48, Iss. 3, pp. 745-766
Closed Access | Times Cited: 53
A story of the potential effect of non-steroidal anti-inflammatory drugs (NSAIDs) in Parkinson’s disease: beneficial or detrimental effects
Mohammed Alrouji, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Inflammopharmacology (2023) Vol. 31, Iss. 2, pp. 673-688
Closed Access | Times Cited: 27
Mohammed Alrouji, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Inflammopharmacology (2023) Vol. 31, Iss. 2, pp. 673-688
Closed Access | Times Cited: 27
Neuropilin-1 promotes mitochondrial structural repair and functional recovery in rats with cerebral ischemia
Ting Guo, Manli Chen, Liu Ji, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 24
Ting Guo, Manli Chen, Liu Ji, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 24
The classical and non-classical axes of renin-angiotensin system in Parkinson disease: The bright and dark side of the moon
Hayder M. Al‐kuraishy, Sadiq M. Al‐Hamash, Majid S. Jabir, et al.
Ageing Research Reviews (2024) Vol. 94, pp. 102200-102200
Closed Access | Times Cited: 10
Hayder M. Al‐kuraishy, Sadiq M. Al‐Hamash, Majid S. Jabir, et al.
Ageing Research Reviews (2024) Vol. 94, pp. 102200-102200
Closed Access | Times Cited: 10
Targeting of neuroinflammation by glibenclamide in Covid-19: old weapon from arsenal
Gaber El‐Saber Batiha, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Inflammopharmacology (2022) Vol. 31, Iss. 1, pp. 1-7
Open Access | Times Cited: 37
Gaber El‐Saber Batiha, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Inflammopharmacology (2022) Vol. 31, Iss. 1, pp. 1-7
Open Access | Times Cited: 37
Hypoxia-Inducible Factor 1 and Preeclampsia: A New Perspective
Sarah Albogami, Hayder M. Al‐kuraishy, Thabat J. Al‐Maiahy, et al.
Current Hypertension Reports (2022) Vol. 24, Iss. 12, pp. 687-692
Closed Access | Times Cited: 30
Sarah Albogami, Hayder M. Al‐kuraishy, Thabat J. Al‐Maiahy, et al.
Current Hypertension Reports (2022) Vol. 24, Iss. 12, pp. 687-692
Closed Access | Times Cited: 30
Cholinergic dysfunction in COVID-19: frantic search and hoping for the best
Eman Hassan Nadwa, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2022) Vol. 396, Iss. 3, pp. 453-468
Open Access | Times Cited: 28
Eman Hassan Nadwa, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2022) Vol. 396, Iss. 3, pp. 453-468
Open Access | Times Cited: 28
The potential therapeutic effect of phosphodiesterase 5 inhibitors in the acute ischemic stroke (AIS)
Raed AlRuwaili, Hayder M. Al‐kuraishy, Mubarak Alruwaili, et al.
Molecular and Cellular Biochemistry (2023) Vol. 479, Iss. 5, pp. 1267-1278
Open Access | Times Cited: 15
Raed AlRuwaili, Hayder M. Al‐kuraishy, Mubarak Alruwaili, et al.
Molecular and Cellular Biochemistry (2023) Vol. 479, Iss. 5, pp. 1267-1278
Open Access | Times Cited: 15
The potential role of SARS‐CoV‐2 infection in acute coronary syndrome and type 2 myocardial infarction (T2MI): Intertwining spread
Aseel Awad Alsaidan, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Immunity Inflammation and Disease (2023) Vol. 11, Iss. 3
Open Access | Times Cited: 14
Aseel Awad Alsaidan, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Immunity Inflammation and Disease (2023) Vol. 11, Iss. 3
Open Access | Times Cited: 14
Neurovascular unit, neuroinflammation and neurodegeneration markers in brain disorders
Duraisamy Kempuraj, Kirk D. Dourvetakis, Jessica R. Cohen, et al.
Frontiers in Cellular Neuroscience (2024) Vol. 18
Open Access | Times Cited: 5
Duraisamy Kempuraj, Kirk D. Dourvetakis, Jessica R. Cohen, et al.
Frontiers in Cellular Neuroscience (2024) Vol. 18
Open Access | Times Cited: 5
Escala de estado funcional post-COVID-19: concordancia entre la versión administrada por evaluador versus autoevaluada en pacientes con síndrome post-COVID-19
Jhonatan Betancourt-Peña, J. Rodriguez-Castro, Valeria Pérez-Hortua, et al.
Rehabilitación (2025) Vol. 59, Iss. 1, pp. 100878-100878
Closed Access
Jhonatan Betancourt-Peña, J. Rodriguez-Castro, Valeria Pérez-Hortua, et al.
Rehabilitación (2025) Vol. 59, Iss. 1, pp. 100878-100878
Closed Access
The possible therapeutic role of advanced glycation end-product inhibitors in ischemic stroke
Nada H. Aljarba, Hayder Alkuraishy, Ali I. Al‐Gareeb, et al.
Brain Research Bulletin (2025) Vol. 222, pp. 111236-111236
Open Access
Nada H. Aljarba, Hayder Alkuraishy, Ali I. Al‐Gareeb, et al.
Brain Research Bulletin (2025) Vol. 222, pp. 111236-111236
Open Access
The Possible Role of Metformin and Fibroblast Growth Factor‐21 in Multiple Sclerosis Neuropathology: Birds of a Feather Flock Together
Ahmad Abulaban, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
European Journal of Neuroscience (2025) Vol. 61, Iss. 7
Open Access
Ahmad Abulaban, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
European Journal of Neuroscience (2025) Vol. 61, Iss. 7
Open Access
Dysregulation of proBDNF/p75NTR and BDNF/TrkB Signaling in Acute Ischemic Stroke: Different Sides of the Same Coins
Hala Alnoaman, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Brain Research Bulletin (2025), pp. 111338-111338
Open Access
Hala Alnoaman, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Brain Research Bulletin (2025), pp. 111338-111338
Open Access
Mixed storm in SARS‐CoV‐2 infection: A narrative review and new term in the Covid‐19 era
Basil Mohammed Alomair, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Immunity Inflammation and Disease (2023) Vol. 11, Iss. 4
Open Access | Times Cited: 11
Basil Mohammed Alomair, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Immunity Inflammation and Disease (2023) Vol. 11, Iss. 4
Open Access | Times Cited: 11
Pharmacological characterization of the antidiabetic drug metformin in atherosclerosis inhibition: A comprehensive insight
Areej Turkistani, Haydar M. Al‐Kuraishy, Ali I. Al‐Gareeb, et al.
Immunity Inflammation and Disease (2024) Vol. 12, Iss. 8
Open Access | Times Cited: 4
Areej Turkistani, Haydar M. Al‐Kuraishy, Ali I. Al‐Gareeb, et al.
Immunity Inflammation and Disease (2024) Vol. 12, Iss. 8
Open Access | Times Cited: 4
Exogenous Players in Mitochondria-Related CNS Disorders: Viral Pathogens and Unbalanced Microbiota in the Gut-Brain Axis
Irene Righetto, Matteo Gasparotto, Laura Casalino, et al.
Biomolecules (2023) Vol. 13, Iss. 1, pp. 169-169
Open Access | Times Cited: 10
Irene Righetto, Matteo Gasparotto, Laura Casalino, et al.
Biomolecules (2023) Vol. 13, Iss. 1, pp. 169-169
Open Access | Times Cited: 10
SARS-CoV-2 infection and dysregulation of nuclear factor erythroid-2-related factor 2 (Nrf2) pathway
Rabab S. Hamad, Hayder M. Al‐kuraishy, Αθανάσιος Αλεξίου, et al.
Cell Stress and Chaperones (2023) Vol. 28, Iss. 6, pp. 657-673
Open Access | Times Cited: 10
Rabab S. Hamad, Hayder M. Al‐kuraishy, Αθανάσιος Αλεξίου, et al.
Cell Stress and Chaperones (2023) Vol. 28, Iss. 6, pp. 657-673
Open Access | Times Cited: 10
The probable role of tissue plasminogen activator/neuroserpin axis in Alzheimer’s disease: a new perspective
Naif H. Ali, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Acta Neurologica Belgica (2023) Vol. 124, Iss. 2, pp. 377-388
Open Access | Times Cited: 10
Naif H. Ali, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Acta Neurologica Belgica (2023) Vol. 124, Iss. 2, pp. 377-388
Open Access | Times Cited: 10
Exploration of multifaceted molecular mechanism of angiotensin-converting enzyme 2 (ACE2) in pathogenesis of various diseases
Aditi D. Kunvariya, Shivani A. Dave, Zeal J. Modi, et al.
Heliyon (2023) Vol. 9, Iss. 5, pp. e15644-e15644
Open Access | Times Cited: 9
Aditi D. Kunvariya, Shivani A. Dave, Zeal J. Modi, et al.
Heliyon (2023) Vol. 9, Iss. 5, pp. e15644-e15644
Open Access | Times Cited: 9
Is neuropilin-1 the neuroimmune initiator of multi-system hyperinflammation in COVID-19?
Kiarash Saleki, Parsa Alijanizadeh, Abbas Azadmehr
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115558-115558
Open Access | Times Cited: 9
Kiarash Saleki, Parsa Alijanizadeh, Abbas Azadmehr
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115558-115558
Open Access | Times Cited: 9
Potential role of tirzepatide towards Covid-19 infection in diabetic patients: a perspective approach
Gaber El‐Saber Batiha, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Inflammopharmacology (2023) Vol. 31, Iss. 4, pp. 1683-1693
Open Access | Times Cited: 8
Gaber El‐Saber Batiha, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Inflammopharmacology (2023) Vol. 31, Iss. 4, pp. 1683-1693
Open Access | Times Cited: 8